Biogen (BIIB) PT Lowered to $240 at RBC Capital

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KEYS
3. KLAR
4. PANW
5. SPY

6. MRK
7. HD
8. DVLT
9. LOW
10. PGR

July 30, 2026 8:32 AM EDT

Price: $221.56 +4.24%

Rating Summary:
28 Buy, 15 Hold, 1 Sell

Rating Trend:

Up

Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24

RBC Capital analyst Brian Abrahams lowered the price target on Biogen (NASDAQ: BIIB) to $240.00 (from $242.00) while maintaining a Outperform rating.

Analyst PT Change

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!